{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:49:35Z","timestamp":1792532975210,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005668","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Distrito Federal","doi-asserted-by":"publisher","award":["00193-00000180\/2019-91"],"award-info":[{"award-number":["00193-00000180\/2019-91"]}],"id":[{"id":"10.13039\/501100005668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005668","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Distrito Federal","doi-asserted-by":"publisher","award":["193.000.805\/2015"],"award-info":[{"award-number":["193.000.805\/2015"]}],"id":[{"id":"10.13039\/501100005668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Scholarship"],"award-info":[{"award-number":["Scholarship"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s42770-024-01293-2","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T17:01:46Z","timestamp":1709571706000},"page":"1349-1357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Resazurin to determine the minimum inhibitory concentration on antifungal susceptibility assays for Fonsecaea sp. using a modified EUCAST protocol"],"prefix":"10.1007","volume":"55","author":[{"given":"Tatiana Sobianski","family":"Herman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"da Silva Goersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamelia Lorenzetti","family":"Bocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2814-7501","authenticated-orcid":false,"given":"Larissa","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"1293_CR1","doi-asserted-by":"publisher","unstructured":"de Brito AC, de J. S. Bittencourt M (2018) Chromoblastomycosis: An etiological, epidemiological, clinical, diagnostic, and treatment update. An Bras Dermatol 93(4):495\u2013506. https:\/\/doi.org\/10.1590\/abd1806-4841.20187321","DOI":"10.1590\/abd1806-4841.20187321"},{"key":"1293_CR2","doi-asserted-by":"crossref","unstructured":"De Queiroz-telles F et al. (2017) Chromoblastomycosis. Clin Microbiol Rev 30(1):233\u2013276, [Online]. Available: http:\/\/cmr.asm.org\/content\/30\/1\/233.long","DOI":"10.1128\/CMR.00032-16"},{"issue":"4","key":"1293_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/jof6040204","volume":"6","author":"DWCL Santos","year":"2020","unstructured":"Santos DWCL et al (2020) Chromoblastomycosis in an endemic area of Brazil: a clinical-epidemiological analysis and a worldwide haplotype network. J Fungi 6(4):204. https:\/\/doi.org\/10.3390\/jof6040204","journal-title":"J Fungi"},{"key":"1293_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/9742832","volume":"2021","author":"LFD Passero","year":"2021","unstructured":"Passero LFD, Cavallone IN, Belda W (2021) Reviewing the etiologic agents, microbe-host relationship, immune response, diagnosis, and treatment in chromoblastomycosis. J Immunol Res 2021:1\u201323. https:\/\/doi.org\/10.1155\/2021\/9742832","journal-title":"J Immunol Res"},{"key":"1293_CR5","unstructured":"World Health Organization (2017) Neglected Tropical Diseases. Program. Available online: http:\/\/www.who.int\/neglected_diseases\/en\/. Accessed 10 Jan 2024"},{"issue":"11","key":"1293_CR6","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1016\/S1473-3099(17)30306-7","volume":"17","author":"F Queiroz-Telles","year":"2017","unstructured":"Queiroz-Telles F, Fahal AH, Falci DR, Caceres DH, Chiller T, Pasqualotto AC (2017) Neglected endemic mycoses. Lancet Infect Dis 17(11):e367\u2013e377. https:\/\/doi.org\/10.1016\/S1473-3099(17)30306-7","journal-title":"Lancet Infect Dis"},{"issue":"5\u20136","key":"1293_CR7","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1439-0507.2004.00984.x","volume":"47","author":"TS Andrade","year":"2004","unstructured":"Andrade TS, Castro LGM, Nunes RS, Gimenes VMF, Cury AE (2004) Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents. Antimykotika-Empfindlichkeit von sequenziellen Fonsecaea pedrosoi-Isolaten von Chromoblastomykose-Patienten. Mycoses 47(5\u20136):216\u2013221. https:\/\/doi.org\/10.1111\/j.1439-0507.2004.00984.x","journal-title":"Mycoses"},{"issue":"4","key":"1293_CR8","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1128\/AAC.01655-09","volume":"54","author":"MJ Najafzadeh","year":"2010","unstructured":"Najafzadeh MJ, Badali H, Illnait-Zaragozi MT, De Hoog GS, Meis JF (2010) In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. Antimicrob Agents Chemother 54(4):1636\u20131638. https:\/\/doi.org\/10.1128\/AAC.01655-09","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1293_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/myc.12111","volume":"57","author":"TC Daboit","year":"2014","unstructured":"Daboit TC et al (2014) In vitro susceptibility of chromoblastomycosis agents to five antifungal drugs and to the combination of terbinafine and amphotericin B. Mycoses 57(2):116\u2013120. https:\/\/doi.org\/10.1111\/myc.12111","journal-title":"Mycoses"},{"key":"1293_CR10","doi-asserted-by":"publisher","unstructured":"Zheng H et al (2019) In vitro susceptibility of dematiaceous fungi to nine antifungal agents determined by two different methods. Mycoses 0\u20133. https:\/\/doi.org\/10.1111\/myc.12895","DOI":"10.1111\/myc.12895"},{"issue":"6","key":"1293_CR11","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3109\/13693780903503081","volume":"48","author":"MJ Najafzadeh","year":"2010","unstructured":"Najafzadeh MJ, Sun J, Vicente V, Xi L, Van Den Ende AHGG, De Hoog GS (2010) Fonsecaea nubica sp. nov, a new agent of human chromoblastomycosis revealed using molecular data. Med Mycol 48(6):800\u2013806. https:\/\/doi.org\/10.3109\/13693780903503081","journal-title":"Med Mycol"},{"issue":"2","key":"1293_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/mmy\/myz034","volume":"58","author":"TS de Andrade","year":"2019","unstructured":"de Andrade TS et al (2019) Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: clinicopathology, susceptibility, and molecular identification. Med Mycol 58(2):172\u2013180. https:\/\/doi.org\/10.1093\/mmy\/myz034","journal-title":"Med Mycol"},{"key":"1293_CR13","unstructured":"Arendrup MC, Meletiadis J, Mouton JW, Guinea J, Cuenca-Estrella M, Lagrou K et al (2021) The Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). Method for the Determination of Broth Dilution Minimum Inhibitory Concentrations of Antifungal Agents for Conidia Forming Moulds. EUCAST E.Def. 9.3.2 2020, pp 1\u201323. Available online: https:\/\/www.eucast.org\/astoffungi\/methodsinantifungalsusceptibilitytesting\/ast_of_moulds\/. Accessed 1 Jan 2023"},{"key":"1293_CR14","unstructured":"Clinical and Laboratory Standards Institute (2017) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard, 3rd ed CLSI document M38-A3. Clinical and Laboratory Standards Institute, Wayne, PA"},{"issue":"4","key":"1293_CR15","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1177\/1087057111433459","volume":"17","author":"MC Monteiro","year":"2012","unstructured":"Monteiro MC et al (2012) A new approach to drug discovery: high-throughput screening of microbial natural extracts against Aspergillus fumigatus using resazurin. J Biomol Screen 17(4):542\u2013549. https:\/\/doi.org\/10.1177\/1087057111433459","journal-title":"J Biomol Screen"},{"key":"1293_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-6960-9_1","volume-title":"Cell Viability Assays. Methods in Molecular Biology","author":"K Pr\u00e4bst","year":"2017","unstructured":"Pr\u00e4bst K, Engelhardt H, Ringgeler S, H\u00fcbner H (2017) Basic colorimetric proliferation assays: MTT, WST, and resazurin. In: Gilbert D, Friedrich O (eds) Cell Viability Assays. Methods in Molecular Biology, vol 1601. Humana Press, New York, NY. https:\/\/doi.org\/10.1007\/978-1-4939-6960-9_1"},{"issue":"9","key":"1293_CR17","doi-asserted-by":"publisher","first-page":"12347","DOI":"10.3390\/s120912347","volume":"12","author":"SN Rampersad","year":"2012","unstructured":"Rampersad SN (2012) Multiple applications of alamar blue as an indicator of metabolic function and cellular health in cell viability bioassays. Sensors (Switzerland) 12(9):12347\u201312360. https:\/\/doi.org\/10.3390\/s120912347","journal-title":"Sensors (Switzerland)"},{"issue":"2","key":"1293_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2020.547458","volume":"11","author":"O Braissant","year":"2020","unstructured":"Braissant O, Astasov-Frauenhoffer M, Waltimo T, Bonkat G (2020) A review of methods to determine viability, vitality, and metabolic rates in microbiology. Front Microbiol 11(2):1\u201325. https:\/\/doi.org\/10.3389\/fmicb.2020.547458","journal-title":"Front Microbiol"},{"key":"1293_CR19","unstructured":"Riss TL, Moravec RA, Niles AL, Duellman S, Benink HA, Worzella TJ, Minor L (2004) Cell Viability Assays. 2013 May 1 [updated 2016 Jul 1]. In: Markossian S, Grossman A, Brimacombe K, Arkin M, Auld D, Austin C, Baell J, Chung TDY, Coussens NP, Dahlin JL, Devanarayan V, Foley TL, Glicksman M, Gorshkov K, Haas JV, Hall MD, Hoare S, Inglese J, Iversen PW, Kales SC, Lal-Nag M, Li Z, McGee J, McManus O, Riss T, Saradjian P, Sittampalam GS, Tarselli M, Trask OJ Jr, Wang Y, Weidner JR, Wildey MJ, Wilson K, Xia M, Xu X (eds) Assay Guidance Manual [Internet]. Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda (MD)"},{"issue":"7","key":"1293_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/13693780701581458","volume":"45","author":"KK Repp","year":"2007","unstructured":"Repp KK, Menor SA, Pettit RK (2007) Microplate Alamar blue assay for susceptibility testing of Candida albicans biofilms. Med Mycol 45(7):603\u2013607. https:\/\/doi.org\/10.1080\/13693780701581458","journal-title":"Med Mycol"},{"key":"1293_CR21","doi-asserted-by":"publisher","unstructured":"Deng S et al. (2018) Combination of amphotericin B and terbinafine against melanized fungi associated with chromoblastomycosis. Antimicrob Agents Chemother (March):AAC.00270\u201318. https:\/\/doi.org\/10.1128\/AAC.00270-18","DOI":"10.1128\/AAC.00270-18"},{"issue":"September","key":"1293_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2020.570975","volume":"11","author":"R Temmerman","year":"2020","unstructured":"Temmerman R et al (2020) Agreement of quantitative and qualitative antimicrobial susceptibility testing methodologies: the case of enrofloxacin and avian pathogenic escherichia coli. Front Microbiol 11(September):1\u20138. https:\/\/doi.org\/10.3389\/fmicb.2020.570975","journal-title":"Front Microbiol"},{"key":"1293_CR23","doi-asserted-by":"publisher","unstructured":"Arendrup MC, Friberg N, Mares M, Kahlmeter G, Meletiadis J, Guinea J (2020) Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST). Clin Microbiol Infect 26(11):1464\u20131472. https:\/\/doi.org\/10.1016\/j.cmi.2020.06.007","DOI":"10.1016\/j.cmi.2020.06.007"},{"issue":"9\u201310","key":"1293_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1046\/j.1439-0507.1999.00511.x","volume":"42","author":"CA Kauffman","year":"1999","unstructured":"Kauffman CA, Zarins LT (1999) Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species. Mycoses 42(9\u201310):539\u2013542. https:\/\/doi.org\/10.1046\/j.1439-0507.1999.00511.x","journal-title":"Mycoses"},{"key":"1293_CR25","doi-asserted-by":"publisher","unstructured":"De Paula E Silva ACA et al (2013) Microplate alamarblue assay for paracoccidioides susceptibility testing. J Clin Microbiol 51(4):1250\u20131252. https:\/\/doi.org\/10.1128\/JCM.02914-12","DOI":"10.1128\/JCM.02914-12"},{"issue":"6","key":"1293_CR26","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1128\/JCM.00338-17","volume":"55","author":"C Leong","year":"2017","unstructured":"Leong C, Buttafuoco A, Glatz M, Bosshard PP (2017) Antifungal susceptibility testing of Malassezia spp. with an optimized colorimetric broth microdilution method. J Clin Microbiol 55(6):1883\u20131893. https:\/\/doi.org\/10.1128\/JCM.00338-17","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1293_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s10156-002-0201-y","volume":"8","author":"H Yamaguchi","year":"2002","unstructured":"Yamaguchi H, Uchida K, Nagino K, Matsunaga T (2002) Usefulness of a colorimetric method for testing antifungal drug susceptibilities of Aspergillus species to voriconazole. J Infect Chemother 8(4):374\u2013377. https:\/\/doi.org\/10.1007\/s10156-002-0201-y","journal-title":"J Infect Chemother"},{"issue":"8","key":"1293_CR28","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1128\/jcm.34.8.2039-2041.1996","volume":"34","author":"B Jahn","year":"1996","unstructured":"Jahn B, St\u00fcben A, Bhakdi S (1996) Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl- 2H-tetrazolium bromide and Alamar Blue tests. J Clin Microbiol 34(8):2039\u20132041. https:\/\/doi.org\/10.1128\/jcm.34.8.2039-2041.1996","journal-title":"J Clin Microbiol"},{"issue":"21","key":"1293_CR29","doi-asserted-by":"publisher","first-page":"7102","DOI":"10.1128\/AEM.01560-10","volume":"76","author":"D Mania","year":"2010","unstructured":"Mania D, Hilpert K, Ruden S, Fischer R, Takeshita N (2010) Screening for antifungal peptides and their modes of action in Aspergillus nidulans. Appl Environ Microbiol 76(21):7102\u20137108. https:\/\/doi.org\/10.1128\/AEM.01560-10","journal-title":"Appl Environ Microbiol"},{"key":"1293_CR30","unstructured":"Invitrogen, \u201calamarBlue \u00ae Assay,\u201d Available online: https:\/\/www.thermofisher.com\/document-connect\/document-connect.html?url=https:\/\/assets.thermofisher.com\/TFS-Assets%2FLSG%2Fmanuals%2FAlamarBluePIS.pdf. Accessed 10 Jan 2024"},{"issue":"17","key":"1293_CR31","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","volume":"267","author":"J O\u2019Brien","year":"2000","unstructured":"O\u2019Brien J, Wilson I, Orton T, Pognan F (2000) Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267(17):5421\u20135426. https:\/\/doi.org\/10.1046\/j.1432-1327.2000.01606.x","journal-title":"Eur J Biochem"},{"key":"1293_CR32","doi-asserted-by":"publisher","unstructured":"Borra RC, Lotufo MA, Gagioti SM, de M. Barros F, Andrade PM (2009) A simple method to measure cell viability in proliferation and cytotoxicity assays. Braz Oral Res 23(3):255\u2013262. https:\/\/doi.org\/10.1590\/S1806-83242009000300006","DOI":"10.1590\/S1806-83242009000300006"},{"issue":"5","key":"1293_CR33","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/j.1574-6976.2007.00077.x","volume":"31","author":"ALS Santos","year":"2007","unstructured":"Santos ALS et al (2007) Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis. FEMS Microbiol Rev 31(5):570\u2013591. https:\/\/doi.org\/10.1111\/j.1574-6976.2007.00077.x","journal-title":"FEMS Microbiol Rev"},{"issue":"9","key":"1293_CR34","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.chemosphere.2008.11.078","volume":"74","author":"PB Fai","year":"2009","unstructured":"Fai PB, Grant A (2009) A rapid resazurin bioassay for assessing the toxicity of fungicides. Chemosphere 74(9):1165\u20131170. https:\/\/doi.org\/10.1016\/j.chemosphere.2008.11.078","journal-title":"Chemosphere"},{"issue":"6","key":"1293_CR35","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1128\/JCM.00044-17","volume":"55","author":"M Siopi","year":"2017","unstructured":"Siopi M, Pournaras S, Meletiadis J (2017) Comparative evaluation of sensititre YeastOne and CLSI M38\u2013A2 reference method for antifungal susceptibility testing of Aspergillus spp. against Echinocandins. J Clin Microbiol 55(6):1714\u20131719. https:\/\/doi.org\/10.1128\/JCM.00044-17","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1293_CR36","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1128\/jcm.33.4.915-917.1995","volume":"33","author":"RN Tiballi","year":"1995","unstructured":"Tiballi RN, He X, Zarins LT, Revankar SG, Kauffman CA (1995) Use of colorimetric system for yeast susceptibility testing. J Clin Microbiol 33(4):915\u2013917. https:\/\/doi.org\/10.1128\/jcm.33.4.915-917.1995","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1293_CR37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.mycmed.2018.04.007","volume":"28","author":"FE Far","year":"2018","unstructured":"Far FE, Al-Obaidi MMJ, Desa MNM (2018) Efficacy of modified Leeming-Notman media in a resazurin microtiter assay in the evaluation of in-vitro activity of fluconazole against Malassezia furfur ATCC 14521. J Mycol Med 28(3):486\u2013491. https:\/\/doi.org\/10.1016\/j.mycmed.2018.04.007","journal-title":"J Mycol Med"},{"issue":"4","key":"1293_CR38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ymeth.2007.02.013","volume":"42","author":"M Liu","year":"2007","unstructured":"Liu M, Seidel V, Katerere DR, Gray AI (2007) Colorimetric broth microdilution method for the antifungal screening of plant extracts against yeasts. Methods 42(4):325\u2013329. https:\/\/doi.org\/10.1016\/j.ymeth.2007.02.013","journal-title":"Methods"},{"key":"1293_CR39","doi-asserted-by":"publisher","unstructured":"da S. Hellwig AH, Heidrich D, Zanette RA, Scroferneker ML (2019) In vitro susceptibility of chromoblastomycosis agents to antifungal drugs: a systematic review. J Glob Antimicrob Resist 16:108\u2013114. https:\/\/doi.org\/10.1016\/j.jgar.2018.09.010","DOI":"10.1016\/j.jgar.2018.09.010"},{"issue":"7","key":"1293_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0006675","volume":"12","author":"RA Coelho","year":"2018","unstructured":"Coelho RA et al (2018) Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil. PLoS Negl Trop Dis 12(7):1\u201315. https:\/\/doi.org\/10.1371\/journal.pntd.0006675","journal-title":"PLoS Negl Trop Dis"},{"issue":"5\u20136","key":"1293_CR41","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1439-0507.2004.00984.x","volume":"47","author":"TS Andrade","year":"2004","unstructured":"Andrade TS, Castro LGM, Nunes RS, Gimenes VMF, Cury AE (2004) Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents. Mycoses 47(5\u20136):216\u2013221. https:\/\/doi.org\/10.1111\/j.1439-0507.2004.00984.x","journal-title":"Mycoses"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-024-01293-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-024-01293-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-024-01293-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T02:10:58Z","timestamp":1717639858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-024-01293-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1293"],"URL":"https:\/\/doi.org\/10.1007\/s42770-024-01293-2","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"value":"1517-8382","type":"print"},{"value":"1678-4405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"assertion":[{"value":"7 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}